Clinical Trials Browser

Phase 2 × NSCLC × aflutinib × Clear all

NCT05466149 2025-11-19

Efficacy and Safety of Furmonertinib in Patients With Locally Advanced or Metastatic NSCLC With EGFR Exon 20 Insertion

Phase 2 Active not recruiting

NSCLC

NCT06339242 2024-04-01

A Study of Furmonertinib Combined With Chemotherapy in the Treatment of NSCLC With Leptomeningeal Metastasis

Phase 2 Recruiting

NSCLC

NCT05165355 2022-01-18

ATHEM

Phase 2 Unknown

NSCLC